Bryostatin 1 Plus Paclitaxel in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer

NCT00005849 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: bryostatin 1
DRUG: paclitaxel

Sponsor

University of Chicago

Collaborators

[object Object]